ScienceAlert on MSN
Yawning Does Something Surprising in Your Brain, MRI Scans Reveal
Yawning has an unusual and unexpected effect on the flow of fluid protecting the brain, a recent study reveals, though it's ...
Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology -HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals ...
DelveInsight's Oncolytic Virus Competitive Landscape 2026 report provides comprehensive global coverage of pipeline oncolytic virus therapies across various stages of clinical development. The report ...
JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced the presentation of four ...
The oncolytic virus therapy landscape has expanded steadily over the past decade, with over 100 companies worldwide pursuing clinical or preclinical programs. A few leaders, such as Candel Therapeutic ...
The idea of diagnosing Alzheimer’s with a quick, finger-prick test marks a profound shift in how we could approach ...
Conditions in Gaza’s displacement camps, malnutrition, and Israeli bans on the entry of medicines increase the risk.
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results